| Arrhythmia |
1 |
1 |
| Cardiovascular Risk Management |
0 |
0.91 |
| Cardiomyopathy |
0 |
0.76 |
| Cardiac Arrest |
0 |
0.63 |
| Heart |
0 |
0.56 |
| Cardiometabolic Risk Factors |
0 |
0.48 |
| Hypertension |
0 |
0.48 |
| Valvular Heart Disease |
0 |
0.45 |
| Acute Heart Failure (HF) |
0 |
0.41 |
| Europe |
0 |
0.32 |
| Electrophysiology |
0 |
0.24 |
| Myocardial Infarction (MI) |
0 |
0.2 |
| Electrocardiogram (ECG) |
0 |
0.16 |
| Exercise |
0 |
0.16 |
| Preventive Screening |
0 |
0.16 |
| Resuscitation |
0 |
0.16 |
| Ventricular Tachycardia |
0 |
0.11 |
| Anxiety |
0 |
0.08 |
| Anxiety Disorder |
0 |
0.08 |
| Asystole |
0 |
0.08 |
| Clinical Guidelines |
0 |
0.08 |
| Defibrillator |
0 |
0.08 |
| Dilated Cardiomyopathy |
0 |
0.08 |
| Grant |
0 |
0.08 |
| Hospital |
0 |
0.08 |
| Hyperlipidemia |
0 |
0.08 |
| Hypertrophic Cardiomyopathy |
0 |
0.08 |
| Infarction |
0 |
0.08 |
| Lipids Management |
0 |
0.08 |
| New York |
0 |
0.08 |
| Primary Care |
0 |
0.08 |
| Pulseless Electrical Activity (PEA) |
0 |
0.08 |
| Tachycardia |
0 |
0.08 |